Page last updated: 2024-11-07

coumarin 6

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Coumarin 6 is a bright green fluorescent dye commonly used in microscopy and laser applications. It is synthesized via a multi-step process involving the reaction of 4-methylumbelliferone with 2-chloro-N,N-diethylaniline. Coumarin 6 exhibits strong fluorescence in the green region of the visible spectrum and has a high quantum yield. It is known for its excellent photostability and resistance to photobleaching, making it suitable for long-term imaging experiments. Coumarin 6 has been widely studied for its potential applications in various fields, including fluorescence microscopy, laser dyes, and biological labeling. Its high fluorescence intensity and photostability make it an ideal probe for imaging cellular structures and processes. Moreover, its chemical properties and spectral characteristics allow for its use in fluorescence-based assays and sensors.'

coumarin 6: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID100334
CHEMBL ID212037
CHEBI ID51942
SCHEMBL ID38421
MeSH IDM0506875

Synonyms (60)

Synonym
EU-0060907
BIDD:GT0525
CHEMDIVAM_000163
CHEMDIV1_000289
38215-36-0
nsc-290432
coumarin 6
OPREA1_603055
3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one
2h-1-benzopyran-2-one, 3-(2-benzothiazolyl)-7-(diethylamino)-
nsc290432
coumarin 6, 98%
3-(1,3-benzothiazol-2-yl)-7-(diethylamino)-2h-chromen-2-one
CHEBI:51942 ,
B2088
3-(2-benzothiazolyl)-7-(diethylamino)coumarin
CHEMBL212037
STK830386
AKOS000813783
HMS587N03
A824060
3-(2'-benzothiazolyl)-7-diethylaminocoumarin; 3-(2-benzothiazolyl)-n,n-diethylumbelliferylamine
nsc 290432
48du8q9uau ,
einecs 253-830-2
unii-48du8q9uau
3-(benzothiazol-2-yl)-7-(diethylamino)-2-benzopyrone
FT-0639438
S5170
3-(benzo[d]thiazol-2-yl)-7-(diethylamino)-2h-chromen-2-one
F0037-2885
VBVAVBCYMYWNOU-UHFFFAOYSA-N
SCHEMBL38421
DTXSID5068079
coumarin-6
J-100033
coumarin6
mfcd00041869
3-(2-benzthiazolyl)-7-diethylaminocoumarin
sr-01000393264
SR-01000393264-1
coumarin 6, >=99%
coumarin 540
coumarin vi
HY-N7131
3-(2-benzothiazolyl)-7-(diethylamino) coumarin
AS-35299
Q27123017
AMY10384
CCG-268032
CS-W009809
2-m-tolylethanesulfonylchloride
SB66543
coumarin 6 is known as a fluorochrome laser dye.
3-(2-benzothiazolyl)-7-diethylaminocoumarin
3-benzothiazol-2-yl-7-diethylamino-chromen-2-one
coumarin, 3-(2-benzothiazolyl)-7-(diethylamino)-
3-(2-benzothiazolyl)-7-(diethylamino)-2h-1-benzopyran-2-one
nk-1858
EN300-7401773

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Therefore, we concluded that the imaging agent is a safe and stable probe which remains in the large intestine without systemic exposure."( A potential of peanut agglutinin-immobilized fluorescent nanospheres as a safe candidate of diagnostic drugs for colonoscopy.
Gore, JC; Higashino, H; Hiwatari, K; Kataoka, M; Kimura, R; Kumagai, H; Masaoka, Y; Nakamura, K; Pham, W; Sakuma, S; Tachikawa, H; Yamashita, S; Yano, T, 2011
)
0.37
" The no observable adverse effect levels (NOAEL) of the nanobeacon in 7-day consecutive oral administration and single intrarectal administration were estimated to be more than 1000mg/kg/day and 50mg/kg/day, respectively."( Toxicity studies of coumarin 6-encapsulated polystyrene nanospheres conjugated with peanut agglutinin and poly(N-vinylacetamide) as a colonoscopic imaging agent in rats.
Gore, JC; Hiwatari, K; Ikejima, T; Kitamura, T; Koike, S; Kumagai, H; McClure, R; Mohri, K; Pham, W; Sakuma, S; Shimosato, M; Tobita, E, 2015
)
0.74

Bioavailability

ExcerptReferenceRelevance
" Pharmacokinetic study in rats demonstrated that the polymeric micellar nanoparticles significantly enhanced the bioavailability of PTX than Taxol."( Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
Chen, L; Chen, Y; Fang, X; Gao, X; Gu, J; Jiang, X; Jiang, Y; Law, K; Ren, Q; Ren, X; Sha, X; Wang, X; Xin, H, 2011
)
0.37
"A novel drug delivery system, TPGS 1000 (TPGS) emulsified zein nanoparticles (TZN), were designed with an objective to improve the oral bioavailability of daidzin, an isoflavone glycoside with estrogenic activities."( TPGS emulsified zein nanoparticles enhanced oral bioavailability of daidzin: in vitro characteristics and in vivo performance.
Gu, L; Zou, T, 2013
)
0.39
"In vitro studies of ocular bioavailability of active pharmaceutical ingredients (API) from colloidal drug delivery systems do not consider physiological shear stress generated by eyelid wiping and tear flow."( Cellular uptake of coumarin-6 under microfluidic conditions into HCE-T cells from nanoscale formulations.
Al-Halhouli, AT; Bartels, J; Behrends, S; Büttgenbach, S; Dahl, K; Dietzel, A; Finke, JH; Krull, R; Lorenz, T; Müller-Goymann, CC; Peterat, G; Pretor, S; Reichl, S, 2015
)
0.42
"Nanoparticulate drug delivery systems, mucoadhesive polymers and penetration enhancers have been used individually to overcome ocular barriers and increase bioavailability to eye tissues."( Understanding the influence of surface properties of nanoparticles and penetration enhancers for improving bioavailability in eye tissues in vivo.
Katti, DS; Mahaling, B, 2016
)
0.43
"8 nm) showed very high physical stability, negligible hemolysis, 428% enhancement in bioavailability with significantly higher intratumoral uptake."( Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer.
Behl, G; Boakye, CH; Chowdhury, N; Doddapaneni, R; Patel, K; Singh, M, 2016
)
0.43
" SNEDDS formulation components were rationally selected and optimized for maximum drug loading by applying the design of experiments and further evaluated for stability in simulated gastrointestinal fluids, functional stability of antioxidants, in vitro release, Caco-2 cell uptake, oral bioavailability and prophylactic anticancer activity."( α-Tocopherol as functional excipient for resveratrol and coenzyme Q10-loaded SNEDDS for improved bioavailability and prophylaxis of breast cancer.
Agrawal, AK; Dora, CP; Garg, T; Jain, S; Kushwah, V; Thanki, K, 2017
)
0.46
" These findings indicate that RA micelle formulations have great potential as a novel ocular drug-delivery system to improve the bioavailability of hydrophobic drugs."( Novel ultra-small micelles based on rebaudioside A: A potential nanoplatform for ocular drug delivery.
Guo, H; Li, J; Li, M; Song, K; Tan, Y; Wu, X; Xin, M; Yu, H; Zheng, Z, 2018
)
0.48
"Development of topically administered drug delivery systems for the treatment of ocular diseases have majorly focused on enhancing bioavailability of drugs in the ocular tissues."( Spatio-temporal control on the delivery of triamcinolone acetonide using polymeric nanoparticles reduces steroid induced cataract.
Katti, DS; Reddy, GB; Reddy, SS; Srinivasarao, DA, 2019
)
0.51
" However its drawbacks of low bioavailability and big individual difference remain to be improved in clinical application."( Rapamycin loaded TPGS-Lecithins-Zein nanoparticles based on core-shell structure for oral drug administration.
Lv, H; Xie, Z; Zhang, Z, 2019
)
0.51
"The global aim of this research was to develop and evaluate self-microemulsifying drug delivery system (SMEDDS) to improve oral bioavailability of Lurasidone Hydrochloride (LH)."( Self microemulsifying drug delivery system of lurasidone hydrochloride for enhanced oral bioavailability by lymphatic targeting: In vitro, Caco-2 cell line and in vivo evaluation.
Patel, MH; Sawant, KK, 2019
)
0.51
"Because of their excellent capacity to significantly improve the bioavailability and solubility of chemotherapy drugs, block copolymer micelles are widely utilized for chemotherapy drug delivery."( Tumor-targeting peptide functionalized PEG-PLA micelles for efficient drug delivery.
Cai, Y; Gao, X; Shuai, Q; Sun, X; Xu, J; Xu, Z; Zhu, F, 2020
)
0.56
"Nanocrystals (NCs) exhibit potential in improving oral bioavailability for poorly water-soluble drugs."( FRET imaging revealed that nanocrystals enhanced drug oral absorption by dissolution rather than endocytosis: A case study of coumarin 6.
Fu, Q; He, Z; Liu, Y; Wang, Y; Zhang, G; Zhang, Z, 2021
)
0.83

Dosage Studied

ExcerptRelevanceReference
" OPTN could be acted as a novel and new dosage form to be used in cancer treatment study."( A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
Bao, X; Chu, QC; Gao, M; Guan, X; Jiang, N; Liu, KX; Tian, Y; Xu, H; Zhang, CH, 2015
)
0.42
" The liver-targeting RPTN, which displayed enhanced pharmacological effects and decreased toxicity for the loaded drug RBG, is therefore a promising intravenous dosage form that may be useful in the treatment of liver cancer."( Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
Chu, Q; Deng, S; Gao, M; Guan, X; Huo, X; Liu, H; Liu, K; Ma, X; Tian, Y; Xu, H, 2016
)
0.43
"It can be concluded that the semisolid SLNs are promising alternative dermal drug delivery systems to the conventional dosage forms."( Novel Drug Delivery System for Dermal Uptake of Etofenamate: Semisolid SLN Dispersion.
Amasya, G; Badilli, U; Sengel-Turk, CT; Tarimci, N, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
7-aminocoumarinsAny member of the class of coumarins that contains a 7-amino-2H-chromen-2-one skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID270399Antiproliferative activity against human HeLa cell line2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Synthesis and anti-angiogenesis activity of coumarin derivatives.
AID270398Antiproliferative activity against mouse B16 cell line2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Synthesis and anti-angiogenesis activity of coumarin derivatives.
AID270401Antiproliferative activity against human SiHa cell line2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Synthesis and anti-angiogenesis activity of coumarin derivatives.
AID270397Antiproliferative activity against human U87 MG cell line2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Synthesis and anti-angiogenesis activity of coumarin derivatives.
AID592669Inhibition of amyloid beta (1 to 40) monomer aggregation assessed as lag time extension by thioflavin T based fluorometric assay relative to control2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center.
AID270402Antiproliferative activity against mouse NIH3T3 cell line2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Synthesis and anti-angiogenesis activity of coumarin derivatives.
AID592670Inhibition of amyloid beta (1 to 40) monomer aggregation assessed as reduction in plateau fluorescence by thioflavin T based fluorometric assay2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center.
AID270403Antiproliferative activity against HUVEC cell line2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Synthesis and anti-angiogenesis activity of coumarin derivatives.
AID270400Antiproliferative activity against human DLD1 cell line2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Synthesis and anti-angiogenesis activity of coumarin derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (171)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (7.60)29.6817
2010's144 (84.21)24.3611
2020's14 (8.19)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.97 (24.57)
Research Supply Index5.15 (2.92)
Research Growth Index5.38 (4.65)
Search Engine Demand Index61.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.58%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other171 (99.42%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]